Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: A report from the Bone Marrow Transplant Survivor Study

Blood

Volumn 108, Issue 8, 2006, Pages 2867-2873

  Fraser, Christopher J ^b   Bhatia, Smita ^b   Ness, Kirsten ^b   Carter, Andrea ^b   Francisco, Liton ^b   Arora, Mukta ^b   Parker, Pablo ^b   Forman, Stephen ^b   Weisdorf, Daniel ^b   Gurney, James G ^b   Baker, K Scott ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; FEMALE; GRAFT VERSUS HOST REACTION; HEALTH STATUS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; SURVIVAL; ALLOTRANSPLANTATION; CHRONIC DISEASE; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RISK; TIME; UNITED STATES;

ADULT; CALIFORNIA; CHRONIC DISEASE; FEMALE; GRAFT VS HOST DISEASE; HEALTH STATUS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MINNESOTA; ODDS RATIO; QUALITY OF LIFE; QUESTIONNAIRES; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 33750616190     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2006-02-003954     Document Type: Article

References (30)

1. Socie G, Salooja N, Cohen A, et al. Nonmalignant late effects after allogeneic stem cell transplantation. Blood. 2003;101:3373-3385.
2. Vogelsang GB. Chronic graft versus host disease. Br J Haematol. 2004;125:435-454.
3. Cutler C, Giri S, Jeyapalan S, Paniagua D, Viswanathan A, Antin JH. Acute and chronic graft versus host disease after allogeneic peripheral blood stem cell and bone marrow transplantation: a meta-analysis. J Clin Oncol. 2001;19:3685-3691.
4. Stewart BL, Storer B, Storek J, et al. Duration of immunosuppressive treatment for chronic graft-versus-host disease. Blood. 2004;104:3501-3506.
5. Arora M, Burns LJ, Davies SM, et al. Chronic graft versus host disease: a prospective cohort study. Biol Blood Marrow Transplant. 2003;9:38-45.
6. Socié G, Stone JV, Wingard JR, et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. N Engl J Med. 1999;341:14-21.
7. Lee SJ, Klein JP, Barrett J, et al. Severity of chronic graft versus host disease: association with treatment-related mortality and relapse. Blood. 2002;100:406-414.
8. Duell T, van Lint MT, Ljungman P, et al. Health and functional status of long-term survivors of bone marrow transplantation. Ann Intern Med. 1997;126:184-192.
9. Syrjala KL, Langer SL, Abrams JR, et al. Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma. JAMA. 2004;291:2335-2343.
10. Chiodi S, Spinelli S, Ravera G, et al. Quality of life in 244 recipients of allogeneic bone marrow transplantation. Br J Haematol. 2000;110:614-619.
11. Kiss TL, Abdolell M, Jamal N, et al. Long term medical outcomes and quality of life assessment of patients with chronic myeloid leukemia followed by at least 10 years after allogeneic bone marrow transplantation. J Clin Oncol. 2002;20:2334-2343.
12. Sutherland HJ, Fyles GM, Adams G, et al. Quality of life following bone marrow transplantation: a comparison of patient reports with population norms. Bone Marrow Transplant. 1997;19:1129-1136.
13. Andrykowski MA, Bishop MM, Hahn EA, et al. Long-term health-related quality of life, growth and spiritual well-being after hematopoietic stem-cell transplantation. J Clin Oncol. 2005;23:599-608.
14. Syrjala KL, Langer SL, Abrams JR, et al. Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls. J Clin Oncol. 2005;23:6596-6606.
15. Lee SJ, Fairclough D, Parsons SK, et al. Recovery after stem-cell transplantation for hematological diseases. J Clin Oncol. 2001;19:242-252.
16. Robison LL, Mertens AC, Boice JD, et al. Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project. Med Pediatr Oncol. 2002;38:229-239.
17. Louie AD, Robison LL, Bogue M, Hyde S, Forman SJ, Bhatia S. Validation of self-reported complications by bone marrow transplantation survivors. Bone Marrow Transplant. 2000;25:1191-1196.
18. Hudson MM, Mertens AC, Yasui Y, et al. Health status of adult long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. JAMA. 2003;290:1583-1592.
19. Derogatis L. Brief Symptom Inventory (BSI) 18: Administration, Scoring, and Procedures Manual. Minneapolis, MN: National Computer Systems; 2000.
20. Zabora J, BrintzenhofeSzoc K, Jacobsen P, et al. A new psychosocial screening instrument for use with cancer patients. Psychosomatics. 2001;42:241-246.
21. Centers for Disease Control and Prevention (CDC). National Health Interview Survey. Atlanta, GA: US Dept of Human Health Services, Centers for Disease Control, and Prevention; 1993.
22. Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey Questionnaire. Atlanta, GA: US Dept of Human Health Services, Centers for Disease Control and Prevention; 1993.
23. Fleiss JL, Levin B, Paik MC. Statistical methods for rates and proportions. 3rd ed. Hoboken, NJ: J. Wiley; 2003.
24. Hosmer DW, Lemeshow S. Applied logistic regression. 2nd ed. New York, NY: J. Wiley; 2001.
25. Allison PD. Logistic Regression Using the SAS System: Theory and Application. Cary, NC: SAS Institute Inc; 1999.
26. Baker KS, Gurney JG, Ness KK, et al. Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: results from the Bone Marrow Transplant Survivor Study. Blood. 2004;104:1898-1906.
27. Pavletic SZ, Martin P, Lee SJ, et al. Measuring therapeutic response in chronic graft versus host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft versus host disease, IV: response criteria working group report. Biol Blood Marrow Transplant. 2006;12:252-266.
28. Akpek G, Zahurak ML, Piantadosi S, et al. Development of a prognostic model for grading chronic graft-versus-host disease. Blood. 2001;97:1219-1226.
29. Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft versus host disease, 1: diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005;11:945-955.
30. Pavletic S, Vogelsang G. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft versus host disease: preface to the series. Biol Blood Marrow Transplant. 2005;11:943-944.